Minigene-Based Splice Assays Reveal the Effect of Non-Canonical Splice Site Variants in USH2A
Abstract
:1. Introduction
2. Results
2.1. Eleven Variants were Selected for Minigene Splice Assays
2.2. Assessment of Pre-mRNA Splicing Using Minigene Splice Assays
3. Discussion
4. Materials and Methods
4.1. Variant Selection
4.2. Minigene Splice Assays
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Sibley, C.R.; Blazquez, L.; Ule, J. Lessons from non-canonical splicing. Nat. Rev. Genet. 2016, 17, 407–421. [Google Scholar] [CrossRef] [PubMed]
- Baux, D.; Vaché, C.; Blanchet, C.; Willems, M.; Baudoin, C.; Moclyn, M.; Faugère, V.; Touraine, R.; Isidor, B.; Dupin-Deguine, D.; et al. Combined genetic approaches yield a 48% diagnostic rate in a large cohort of French hearing-impaired patients. Sci. Rep. 2017, 7, 16783. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liquori, A.; Vaché, C.; Baux, D.; Blanchet, C.; Hamel, C.; Malcolm, S.; Koenig, M.; Claustres, M.; Roux, A.-F. Whole USH2A Gene Sequencing Identifies Several New Deep Intronic Mutations. Hum. Mutat. 2016, 37, 184–193. [Google Scholar] [CrossRef] [PubMed]
- Vaché, C.; Besnard, T.; le Berre, P.; García-García, G.; Baux, D.; Larrieu, L.; Abadie, C.; Blanchet, C.; Bolz, H.J.; Millan, J.; et al. Usher syndrome type 2 caused by activation of an USH2A pseudoexon: Implications for diagnosis and therapy. Hum. Mutat. 2012, 33, 104–108. [Google Scholar] [CrossRef] [PubMed]
- Mansard, L.; Baux, D.; Vaché, C.; Blanchet, C.; Meunier, I.; Willems, M.; Faugère, V.; Baudoin, C.; Moclyn, M.; Bianchi, J.; et al. The Study of a 231 French Patient Cohort Significantly Extends the Mutational Spectrum of the Two Major Usher Genes MYO7A and USH2A. Int. J. Mol. Sci. 2021, 22, 13294. [Google Scholar] [CrossRef] [PubMed]
- Fokkema, I.F.; Kroon, M.; Hernández, J.A.L.; Asscheman, D.; Lugtenburg, I.; Hoogenboom, J.; Dunnen, J.T.D. The LOVD3 platform: Efficient genome-wide sharing of genetic variants. Eur. J. Hum. Genet. 2021, 29, 1796–1803. [Google Scholar] [CrossRef]
- Landrum, M.J.; Lee, J.M.; Benson, M.; Brown, G.R.; Chao, C.; Chitipiralla, S.; Gu, B.; Hart, J.; Hoffman, D.; Jang, W.; et al. ClinVar: Improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018, 46, D1062–D1067. [Google Scholar] [CrossRef] [Green Version]
- Garcia-Garcia, G.; Aparisi, M.J.; Jaijo, T.; Rodrigo, R.; Leon, A.M.; Avila-Fernandez, A.; Blanco-Kelly, F.; Bernal, S.; Navarro, R.; Diaz-Llopis, M.; et al. Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations. Orphanet J. Rare Dis. 2011, 6, 65. [Google Scholar] [CrossRef] [Green Version]
- Le Guédard-Méreuze, S.; Vaché, C.; Baux, D.; Faugère, V.; Larrieu, L.; Abadie, C.; Janecke, A.; Claustres, M.; Roux, A.-F.; Tuffery-Giraud, S. Ex vivo splicing assays of mutations at noncanonical positions of splice sites in USHER genes. Hum. Mutat. 2010, 31, 347–355. [Google Scholar] [CrossRef]
- Jaijo, T.; Aller, E.; Aparisi, M.J.; Hernan, I.; Gamundi, M.; Nájera, C.; García-García, G.; Carballo, M.; Millán, J. Functional analysis of splicing mutations in MYO7A and USH2A genes. Clin. Genet. 2011, 79, 282–288. [Google Scholar] [CrossRef]
- Vaché, C.; Besnard, T.; Blanchet, C.; Baux, D.; Larrieu, L.; Faugère, V.; Mondain, M.; Hamel, C.; Malcolm, S.; Claustres, M.; et al. Nasal epithelial cells are a reliable source to study splicing variants in Usher syndrome. Hum. Mutat. 2010, 31, 734–741. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fadaie, Z.; Whelan, L.; Ben-Yosef, T.; Dockery, A.; Corradi, Z.; Gilissen, C.; Haer-Wigman, L.; Corominas, J.; Astuti, G.D.N.; de Rooij, L.; et al. Whole genome sequencing and in vitro splice assays reveal genetic causes for inherited retinal diseases. NPJ Genom. Med. 2021, 6, 97. [Google Scholar] [CrossRef] [PubMed]
- Dulla, K.; Slijkerman, R.; van Diepen, H.C.; Albert, S.; Dona, M.; Beumer, W.; Turunen, J.J.; Chan, H.L.; Schulkens, I.A.; Vorthoren, L.; et al. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations. Mol. Ther. 2021, 29, 2441–2455. [Google Scholar] [CrossRef] [PubMed]
- Fuster-García, C.; García-García, G.; González-Romero, E.; Jaijo, T.; Sequedo, M.D.; Ayuso, C.; Vázquez-Manrique, R.P.; Millán, J.M.; Aller, E. USH2A Gene Editing Using the CRISPR System. Mol. Ther. Nucleic Acids 2017, 8, 529–541. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pendse, N.D.; Lamas, V.; Pawlyk, B.S.; Maeder, M.L.; Chen, Z.-Y.; Pierce, E.A.; Liu, Q. In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases. Adv. Exp. Med. Biol. 2019, 1185, 91–96. [Google Scholar] [CrossRef]
- Russell, S.; Bennett, J.; Wellman, J.A.; Chung, D.C.; Yu, Z.-F.; Tillman, A.; Wittes, J.; Pappas, J.; Elci, O.; McCague, S.; et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: A randomised, controlled, open-label, phase 3 trial. Lancet 2017, 390, 849–860. [Google Scholar] [CrossRef]
- Cideciyan, A.V.; Jacobson, S.G.; Ho, A.C.; Garafalo, A.V.; Roman, A.J.; Sumaroka, A.; Krishnan, A.K.; Swider, M.; Schwartz, M.R.; Girach, A. Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: A case report. Nat. Med. 2021, 27, 785–789. [Google Scholar] [CrossRef]
- Shapiro, M.B.; Senapathy, P. RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987, 15, 7155–7174. [Google Scholar] [CrossRef] [Green Version]
- Yeo, G.; Burge, C.B. Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals. J. Comput. Biol. 2004, 11, 377–394. [Google Scholar] [CrossRef]
- Reese, M.G.; Eeckman, F.H.; Kulp, D.; Haussler, D. Improved Splice Site Detection in Genie. J. Comput. Biol. 1997, 4, 311–323. [Google Scholar] [CrossRef]
- Pertea, M.; Lin, X.; Salzberg, S.L. GeneSplicer: A new computational method for splice site prediction. Nucleic Acids Res. 2001, 29, 1185–1190. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baux, D.; Blanchet, C.; Hamel, C.; Meunier, I.; Larrieu, L.; Faugère, V.; Vaché, C.; Castorina, P.; Puech, B.; Bonneau, D.; et al. Enrichment of LOVD-USHbases with 152 USH2A Genotypes Defines an Extensive Mutational Spectrum and Highlights Missense Hotspots. Hum. Mutat. 2014, 35, 1179–1186. [Google Scholar] [CrossRef] [PubMed]
- Lenassi, E.; Vincent, A.; Li, Z.; Saihan, Z.; Coffey, A.J.; Steele-Stallard, H.B.; Moore, A.T.; Steel, K.P.; Luxon, L.M.; Héon, E.; et al. A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants. Eur. J. Hum. Genet. 2015, 23, 1318–1327. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reddy, R.; Fahiminiya, S.; El Zir, E.; Mansour, A.; Mégarbané, A.; Majewski, J.; Slim, R. Molecular Genetics of the Usher Syndrome in Lebanon: Identification of 11 Novel Protein Truncating Mutations by Whole Exome Sequencing. PLoS ONE 2014, 9, e107326. [Google Scholar] [CrossRef] [PubMed]
- Jiang, L.; Liang, X.; Li, Y.; Wang, J.; Zaneveld, J.E.; Wang, H.; Xu, S.; Wang, K.; Wang, B.; Chen, R.; et al. Comprehensive molecular diagnosis of 67 Chinese Usher syndrome probands: High rate of ethnicity specific mutations in Chinese USH patients. Orphanet J. Rare Dis. 2015, 10, 110. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Glöckle, N.; Kohl, S.; Mohr, J.; Scheurenbrand, T.; Sprecher, A.; Weisschuh, N.; Bernd, A.; Rudolph, G.; Schubach, M.; Poloschek, C.M.; et al. Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies. Eur. J. Hum. Genet. 2013, 22, 99–104. [Google Scholar] [CrossRef] [Green Version]
- Krawitz, P.M.; Schiska, D.; Krüger, U.; Appelt, S.; Heinrich, V.; Parkhomchuk, D.; Timmermann, B.; Millan, J.M.; Robinson, P.N.; Mundlos, S.; et al. Screening for single nucleotide variants, small indels and exon deletions with a next-generation sequencing based gene panel approach for Usher syndrome. Mol. Genet. Genom. Med. 2014, 2, 393–401. [Google Scholar] [CrossRef]
- Bonnet, C.; Riahi, Z.; Chantot-Bastaraud, S.; Smagghe, L.; Letexier, M.; Marcaillou, C.; Lefèvre, G.M.; Hardelin, J.-P.; El-Amraoui, A.; Singh-Estivalet, A.; et al. An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients. Eur. J. Hum. Genet. 2016, 24, 1730–1738. [Google Scholar] [CrossRef] [Green Version]
- Koyanagi, Y.; Akiyama, M.; Nishiguchi, K.M.; Momozawa, Y.; Kamatani, Y.; Takata, S.; Inai, C.; Iwasaki, Y.; Kumano, M.; Murakami, Y.; et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J. Med. Genet. 2019, 56, 662–670. [Google Scholar] [CrossRef]
- Sangermano, R.; Khan, M.; Cornelis, S.S.; Richelle, V.; Albert, S.; Garanto, A.; Elmelik, D.; Qamar, R.; Lugtenberg, D.; van den Born, L.I.; et al. ABCA4 midigenes reveal the full splice spectrum of all reported noncanonical splice site variants in Stargardt disease. Genome Res. 2018, 28, 100–110. [Google Scholar] [CrossRef]
- Toulis, V.; Cortés-González, V.; de Castro-Miró, M.; Sallum, J.F.; Català-Mora, J.; Villanueva-Mendoza, C.; Ciccioli, M.; Gonzàlez-Duarte, R.; Valero, R.; Marfany, G. Increasing the Genetic Diagnosis Yield in Inherited Retinal Dystrophies: Assigning Pathogenicity to Novel Non-canonical Splice Site Variants. Genes 2020, 11, 378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cremers, F.P.; Lee, W.; Collin, R.W.; Allikmets, R. Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations. Prog. Retin. Eye Res. 2020, 79, 100861. [Google Scholar] [CrossRef] [PubMed]
- Riepe, T.V.; Khan, M.; Roosing, S.; Cremers, F.P.M.; Hoen, P.A.C. Benchmarking deep learning splice prediction tools using functional splice assays. Hum. Mutat. 2021, 42, 799–810. [Google Scholar] [CrossRef] [PubMed]
- Jaganathan, K.; Panagiotopoulou, S.K.; McRae, J.F.; Darbandi, S.F.; Knowles, D.; Li, Y.I.; Kosmicki, J.A.; Arbelaez, J.; Cui, W.; Schwartz, G.B.; et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell 2019, 176, 535–548.e24. [Google Scholar] [CrossRef] [Green Version]
- Rowlands, C.; Thomas, H.B.; Lord, J.; Wai, H.A.; Arno, G.; Beaman, G.; Sergouniotis, P.; Gomes-Silva, B.; Campbell, C.; Gossan, N.; et al. Comparison of in silico strategies to prioritize rare genomic variants impacting RNA splicing for the diagnosis of genomic disorders. Sci. Rep. 2021, 11, 20607. [Google Scholar] [CrossRef]
- Albert, S.; Garanto, A.; Sangermano, R.; Khan, M.; Bax, N.M.; Hoyng, C.B.; Zernant, J.; Lee, W.; Allikmets, R.; Collin, R.W.; et al. Identification and Rescue of Splice Defects Caused by Two Neighboring Deep-Intronic ABCA4 Mutations Underlying Stargardt Disease. Am. J. Hum. Genet. 2018, 102, 517–527. [Google Scholar] [CrossRef] [Green Version]
- Murphy, D.; Cieply, B.; Carstens, R.; Ramamurthy, V.; Stoilov, P. The Musashi 1 Controls the Splicing of Photoreceptor-Specific Exons in the Vertebrate Retina. PLoS Genet. 2016, 12, e1006256. [Google Scholar] [CrossRef] [Green Version]
- Sangermano, R.; Bax, N.M.; Bauwens, M.; Van den Born, L.I.; De Baere, E.; Garanto, A.; Collin, R.W.J.; Goercharn-Ramlal, A.S.A.; den Engelsman-van Dijk, A.H.A.; Rohrschneider, K.; et al. Photoreceptor Progenitor mRNA Analysis Reveals Exon Skipping Resulting from the ABCA4 c.5461-10T→C Mutation in Stargardt Disease. Ophthalmology 2016, 123, 1375–1385. [Google Scholar] [CrossRef]
- Abou Tayoun, A.N.; Pesaran, T.; DiStefano, M.T.; Oza, A.; Rehm, H.L.; Biesecker, L.G.; Harrison, S.M. ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI) Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum. Mutat. 2018, 39, 1517–1524. [Google Scholar] [CrossRef]
- Richards, S.; Aziz, N.; Bale, S.; Bick, D.; Das, S.; Gastier-Foster, J.; Grody, W.W.; Hegde, M.; Lyon, E.; Spector, E.; et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015, 17, 405–424. [Google Scholar] [CrossRef]
NCSS Variant; cDNA (NM_206933.2) | NCSS Variant; Protein | Variant Location | Pheno Type | Reference | SpliceSite Finder-Like | MaxEnt Scan | NN SPLICE | Gene Splicer | Predicted Average Splice Site Strength Decrease (%) | USH2A Variant 2; cDNA, Protein | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WT | M | WT | M | WT | M | WT | M | |||||||
Variants with a predicted effect on canonical splice acceptor sites | ||||||||||||||
c.2994−10T>G | p.(?) | Intron 14 | USH | Personal communication | 88.0 | 82.1 | 9.5 | 8.8 | 1.0 | 0.8 | 8.3 | 6.7 | 13.3 | c.8224del, p.(Val2742Serfs*27) |
c.5168G>A | p. (Gly1723Glu) | Exon 26 | USH | Baux et al. 2014 [22] | 89.1 | 85.2 | 7.9 | 5.8 | 0.9 | 0.7 | 6.2 | 4.6 | 19.7 | c.908G>A, p.(Arg303His) |
Variants with a predicted effect on canonical splice donor sites | ||||||||||||||
c.5167G>C | p. (Gly1723Arg) | Exon 25 | USH | Baux et al. 2014 [22] | 82.6 | 69.3 | 9.4 | 2.3 | 0.8 | 0.1 | 2.4 | 0.0 | 69.8 | c.2276G>T, p.(Cys759Phe) |
c.5776G>A | p. (Glu1926Lys) | Exon 28 | arRP | Lenassi et al. 2015 [23] | 82.6 | 70.5 | 9.4 | 2.1 | 0.6 | 0.1 | 3.7 | 0.0 | 68.9 | c.10073G>A, p.(Cys3358Tyr) |
c.8681G>A | p. (Arg2894Lys) | Exon 43 | USH | Reddy et al. 2014 [24] | 90.3 | 78.2 | 9.2 | 5.3 | 0.6 | 0.1 | 0.0 | 0.0 | 48.0 | c.8681G>A, p.(Arg2894Lys) |
c.9958G>T | p. (Gly3320Cys) | Exon 50 | USH | Jiang et al. 2015 [25] | 95.0 | 82.4 | 11.1 | 6.6 | 1.0 | 0.9 | 8.2 | 4.3 | 27.8 | c.6488G>A, p.(Trp2163*) |
c.10182G>A | p.(Lys3394=) | Exon 51 | arRP | Glöckle et al. 2013 [26] | 87.3 | 75.2 | 8.8 | 3.6 | 1.0 | 0.2 | 1.5 | 0.0 | 63.2 | c.10182G>A, p.(Lys3394=) |
c.10939G>A | p. (Gly3647Ser) | Exon 55 | USH | Krawitz et al. 2014 [27] | 90.3 | 78.2 | 9.2 | 5.3 | 1.0 | 0.3 | 8.9 | 3.9 | 45.5 | c.7139_7140del, p.(Leu2380Profs*37) |
c.11389+3A>G | p.(?) | Intron 58 | USH | Bonnet et al. 2016 [28] | 82.5 | 78.2 | 8.6 | 5.1 | 1.0 | 0.9 | 0.0 | 0.0 | 18.6 | c.2209C>T, p.(Arg737*) |
c.14791+4A>G | p.(?) | Intron 67 | USH | Bonnet et al. 2016 [28] | 82.7 | 72.6 | 7.8 | 2.8 | 1.0 | 0.2 | 5.4 | 0.7 | 60.8 | c.10712C>T, p.(Thr3571Met) |
c.15519+2dup | p.(?) | Intron 71 | arRP | Koyanagi et al. 2019 [29] | 87.1 | 54.4 | 10.1 | 0.0 | 0.9 | 0.0 | 7.7 | 0.0 | 84.4 | c.10859T>C, p.(Ile3620Thr) |
NCSS Variant (NM_206933.2) | Variant Location | Minigene Splice Assay Effects | Protein Effect | ACMG Classification |
---|---|---|---|---|
c.2994−10T>G | Intron 14 | 1. Conventionally spliced mRNA, 2. Skipping of exon 15, (3. Inclusion of a 39-nt PE in both WT and M constructs) | p.[=,Arg998Serfs*26] | VUS |
c.5167G>C | Exon 25 | 1. Dual skipping of exons 25 and 26, 2. skipping of exon 25 | p.[Glu1663Aspfs*31, Glu1663_Ala1722del] | Likely pathogenic |
c.5168G>A | Exon 26 | 1. Dual skipping of exons 25 and 26, 2. skipping of exon 26 | p.[Glu1663Aspfs*31, Gly1723Aspfs*31] | Pathogenic |
c.5776G>A | Exon 28 | Skipping of exon 28 | p.Gly1858_Thr1925del | Likely pathogenic |
c.8681G>A | Exon 43 | Skipping of exon 43 | p.Tyr2854_Arg2894del | Likely pathogenic |
c.9958G>T | Exon 50 | 1. Conventionally spliced mRNA, 2. Skipping of last 61 nt of exon 50, 3. skipping of exon 50 | p.[Gly3320Cys,Ser3301Cysfs*9, Glu3248_Gly3320del] | Likely pathogenic |
c.10182G>A | Exon 51 | Skipping of exon 51 | p.Met3321Asnfs*22 | Pathogenic |
c.10939G>A | Exon 55 | 1. Skipping of exon 55, 2. skipping of last 62 nt of exon 55 | p.[Val3582Serfs*26, Gln3627Serfs*35] | Pathogenic |
c.11389+3A>G | Intron 58 | 1. Skipping of exon 58, 2. skipping of last 43 nt of exon 58, 3. conventionally spliced mRNA, | p.[Tyr3745Aspfs*16, Val3783Glyfs*20,=] | VUS |
c.14791+4A>G | Intron 67 | Skipping of exon 67 | p.Tyr4862Alafs*22 | Pathogenic |
c.15519+2dup | Intron 71 | Skipping of exon 71 | p.Gly5100_Leu5173del | VUS |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Reurink, J.; Oostrik, J.; Aben, M.; Ramos, M.G.; van Berkel, E.; Ołdak, M.; van Wijk, E.; Kremer, H.; Roosing, S.; Cremers, F.P.M. Minigene-Based Splice Assays Reveal the Effect of Non-Canonical Splice Site Variants in USH2A. Int. J. Mol. Sci. 2022, 23, 13343. https://doi.org/10.3390/ijms232113343
Reurink J, Oostrik J, Aben M, Ramos MG, van Berkel E, Ołdak M, van Wijk E, Kremer H, Roosing S, Cremers FPM. Minigene-Based Splice Assays Reveal the Effect of Non-Canonical Splice Site Variants in USH2A. International Journal of Molecular Sciences. 2022; 23(21):13343. https://doi.org/10.3390/ijms232113343
Chicago/Turabian StyleReurink, Janine, Jaap Oostrik, Marco Aben, Mariana Guimarães Ramos, Emma van Berkel, Monika Ołdak, Erwin van Wijk, Hannie Kremer, Susanne Roosing, and Frans P. M. Cremers. 2022. "Minigene-Based Splice Assays Reveal the Effect of Non-Canonical Splice Site Variants in USH2A" International Journal of Molecular Sciences 23, no. 21: 13343. https://doi.org/10.3390/ijms232113343